Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
Plain-language summary
This trial is testing allogeneic stem cell transplant (from a donor) for patients with cutaneous T-cell lymphoma (CTCL), including mycosis fungoides or Sézary syndrome at various stages of their disease. Patients are randomly assigned to different treatment groups. Researchers want to learn whether this approach can help control the lymphoma. This trial does not currently have sites in the United States. The trial is not yet open for recruitment.
Who can join (key eligibility)
- Age 12 Years to 75 Years years
- Must be well enough for treatment (adequate performance status)
Final eligibility is determined by the trial team. This list is a starting point only.
What's being tested
Ossium HPC, Marrow (OTHER): Cryopreserved deceased donor bone marrow | Standard of care living donor - Haplo Related (OTHER): Haplo Related PBSC donor | Standard of care living donor - Mismatched Unrelated (OTHER): Mismatched Unrelated PBSC donor
Ossium HPC, Marrow, Standard of care living donor
Haplo Related, Standard of care living donor — Mismatched Unrelated
- Treatment length
- Ask the trial team for details
- Visit frequency
- Ask the trial team for details